Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma

about

Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma

Item

http://www.wikidata.org/entity/Q58760715

description

scientific article published on 06 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Ruxolitinib inhibits cyclospor ...... aneous squamous cell carcinoma

@en

Ruxolitinib inhibits cyclospor ...... aneous squamous cell carcinoma

@nl

type

Item

label

Ruxolitinib inhibits cyclospor ...... aneous squamous cell carcinoma

@en

Ruxolitinib inhibits cyclospor ...... aneous squamous cell carcinoma

@nl

prefLabel

Ruxolitinib inhibits cyclospor ...... aneous squamous cell carcinoma

@en

Ruxolitinib inhibits cyclospor ...... aneous squamous cell carcinoma

@nl

P1476

Ruxolitinib inhibits cyclospor ...... aneous squamous cell carcinoma

@en

P2093

Alexis L Santana

http://www.w3.org/2001/XMLSchema#string

Charlotte Proby

http://www.w3.org/2001/XMLSchema#string

Diane Felsen

http://www.w3.org/2001/XMLSchema#string

Jie Chen

http://www.w3.org/2001/XMLSchema#string

Nazanin Roudiani

http://www.w3.org/2001/XMLSchema#string

Nicole Doudican

http://www.w3.org/2001/XMLSchema#string

P2860

A simple practice guide for dose conversion between animals and human

The good and the bad faces of STAT1 in solid tumours

Treg cells: a potential regulator for IL-22 expression?

CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity.

Emerging therapies targeting intra-organ inflammation in transplantation

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

limma powers differential expression analyses for RNA-sequencing and microarray studies

Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production.

Skin cancer in organ transplant recipients: more than the immune system.

A population-based study of skin cancer incidence and prevalence in renal transplant recipients.

P31

scholarly article

P356

10.1172/JCI.INSIGHT.120750

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Melody Abikhair Burgo

John Carucci

P577

2018-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30185657

http://www.w3.org/2001/XMLSchema#string

P932

6171807

http://www.w3.org/2001/XMLSchema#string